ProPhase Labs (PRPH) Receivables (2010 - 2026)
ProPhase Labs' Receivables came in at $1.54 million for Q2 2026, down 92.3% from $20.09 million a year earlier and unchanged from the prior quarter.
Powered by 
Analysis
ProPhase Labs (PRPH) Receivables (2010 - 2026) Analysis & Trends
Going back to Q4 2010, ProPhase Labs' Receivables data covers 61 quarters.
- Receivables has declined in each of the last four years, with a five-year compound annual growth rate of -18.9% (FY2020 to FY2025).
- Going back by year, Receivables was $20.06 million in FY2024 (-44.0%), $35.81 million in FY2023 (-9.7%), $39.68 million in FY2022 (-34.7%) and $60.8 million in FY2021.
- The five-year range for quarterly Receivables is $1.54 million (Q4 2025) to $60.8 million (Q4 2021).
- Year-over-year, Receivables has declined for 15 consecutive quarters, with an average decline of 63.8% over the last eight quarters.
- The fastest year-over-year change in Receivables over five years came in Q2 2022 (growth of 553.8%), and the weakest in Q1 2026 (a decline of 92.4%).
- Business Quant data shows PRPH's Receivables at $1.54 million (Q1 2026), $1.54 million (Q4 2025) and $3.28 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,137.66 Bn | 1,106.24 Bn | 19.71 Bn | 23.48 Bn |
| 2 | Johnson & Johnson | 636.13 Bn | 556.00 Bn | 17.30 Bn | 18.99 Bn |
| 3 | AbbVie | 505.28 Bn | 478.39 Bn | 12.70 Bn | 13.82 Bn |
| 4 | Merck | 358.10 Bn | 312.48 Bn | 12.21 Bn | 12.56 Bn |
| 5 | Novartis Ag | 292.59 Bn | 256.58 Bn | 11.24 Bn | 9.64 Bn |
| 6 | Astrazeneca | 265.81 Bn | 239.50 Bn | 12.86 Bn | 15.68 Bn |
| 7 | Amgen | 237.53 Bn | 192.93 Bn | 7.24 Bn | 10.23 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | 5.06 Bn |
| 9 | Pfizer | 171.17 Bn | 117.82 Bn | 10.94 Bn | 12.49 Bn |
| 10 | ProPhase Labs | 120,537.60 | -425,462.40 | 226,000.00 | 1.54 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.54 Mn |
| Mar 31, 2026 | 1.54 Mn |
| Dec 31, 2025 | 1.54 Mn |
| Sep 30, 2025 | 3.28 Mn |
| Jun 30, 2025 | 20.09 Mn |
| Mar 31, 2025 | 20.20 Mn |
| Dec 31, 2024 | 20.06 Mn |
| Sep 30, 2024 | 31.64 Mn |
| Jun 30, 2024 | 32.94 Mn |
| Mar 31, 2024 | 35.12 Mn |
| Dec 31, 2023 | 35.81 Mn |
| Sep 30, 2023 | 38.64 Mn |
| Jun 30, 2023 | 38.57 Mn |
| Mar 31, 2023 | 37.84 Mn |
| Dec 31, 2022 | 39.68 Mn |
| Sep 30, 2022 | 43.86 Mn |
| Jun 30, 2022 | 43.44 Mn |
| Mar 31, 2022 | 51.64 Mn |
| Dec 31, 2021 | 60.80 Mn |
| Sep 30, 2021 | 10.68 Mn |
API Access
ProPhase Labs Receivables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables&ticker=PRPH&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables", "ticker": "PRPH", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables&ticker=PRPH&period=max&api_key=YOUR_API_KEY");
const data = await res.json();